We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for ... Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Show more
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the...
WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...
MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively ~70% improvement in...
WORCESTER, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1729 | -32.5734740015 | 0.5308 | 0.5498 | 0.33 | 354884 | 0.38358907 | CS |
4 | -0.7421 | -67.4636363636 | 1.1 | 1.15 | 0.33 | 270511 | 0.61328096 | CS |
12 | -1.0721 | -74.972027972 | 1.43 | 1.52 | 0.33 | 212718 | 1.01031362 | CS |
26 | -1.3821 | -79.4310344828 | 1.74 | 2.11 | 0.33 | 154811 | 1.16911861 | CS |
52 | -3.4921 | -90.7038961039 | 3.85 | 8.17 | 0.33 | 98008 | 1.95074833 | CS |
156 | -44.6421 | -99.2046666667 | 45 | 60.9 | 0.33 | 640213 | 26.47246159 | CS |
260 | -91.4421 | -99.610130719 | 91.8 | 103.5 | 0.33 | 848418 | 41.76397973 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions